Sakai Chemical Industry Co Ltd (4078):企業の財務・戦略的SWOT分析

◆英語タイトル:Sakai Chemical Industry Co Ltd (4078) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA8013665
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月21日
◆ページ数:31
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:化学・材料
◆販売価格オプション(消費税別)
Single UserUSD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Sakai Chemical Industry Co Ltd (4078) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Sakai Chemical Industry Co Ltd (SCI) is a chemical company that manufacture and sale of organic and inorganic chemicals products, active pharmaceutical ingredients, prescription drugs, and pharmaceutical intermediates. The company offers a wide range of inorganic products that include titanium dioxide, barium oxide, zinc products and strontium oxide. SCI also manufactures barium metal and strontium metal. It provides a comprehensive range of plastic additives such as stabilizers, lubricants, antioxidizing agents, light stabilizers and flame retardants; and catalysts such as hydrogenation catalysts. The company also manufactures electronic materials such as spherical silica and spherical silica dispersion. SCI is headquartered in Sakai, Osaka, Japan.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Section 1 – About the Company 5
Sakai Chemical Industry Co Ltd – Key Facts 5
Sakai Chemical Industry Co Ltd – Key Employees 6
Sakai Chemical Industry Co Ltd – Major Products and Services 7
Sakai Chemical Industry Co Ltd – History 8
Sakai Chemical Industry Co Ltd – Company Statement 9
Sakai Chemical Industry Co Ltd – Locations And Subsidiaries 10
Head Office 10
Other Locations & Subsidiaries 10
Section 2 – Company Analysis 12
Sakai Chemical Industry Co Ltd – Business Description 12
Sakai Chemical Industry Co Ltd – Corporate Strategy 13
Sakai Chemical Industry Co Ltd – SWOT Analysis 14
SWOT Analysis – Overview 14
Sakai Chemical Industry Co Ltd – Strengths 14
Sakai Chemical Industry Co Ltd – Weaknesses 15
Sakai Chemical Industry Co Ltd – Opportunities 16
Sakai Chemical Industry Co Ltd – Threats 17
Sakai Chemical Industry Co Ltd – Key Competitors 18
Section 3 – Company Financial Ratios 19
Financial Ratios – Capital Market Ratios 19
Financial Ratios – Annual Ratios 20
Performance Chart 23
Financial Performance 23
Financial Ratios – Interim Ratios 24
Financial Ratios – Ratio Charts 25
Sakai Chemical Industry Co Ltd, Recent Deals Summary 26
Section 4 – Appendix 27
Methodology 27
Ratio Definitions 27
About GlobalData 31
Contact Us 31
Disclaimer 31

List of Tables
Sakai Chemical Industry Co Ltd, Key Facts 5
Sakai Chemical Industry Co Ltd, Key Employees 6
Sakai Chemical Industry Co Ltd, Major Products and Services 7
Sakai Chemical Industry Co Ltd, History 8
Sakai Chemical Industry Co Ltd, Other Locations 10
Sakai Chemical Industry Co Ltd, Subsidiaries 10
Sakai Chemical Industry Co Ltd, Key Competitors 18
Sakai Chemical Industry Co Ltd, Ratios based on current share price 19
Sakai Chemical Industry Co Ltd, Annual Ratios 20
Sakai Chemical Industry Co Ltd, Annual Ratios (Cont...1) 21
Sakai Chemical Industry Co Ltd, Annual Ratios (Cont...2) 22
Sakai Chemical Industry Co Ltd, Interim Ratios 24
Sakai Chemical Industry Co Ltd, Recent Deals Summary 26
Currency Codes 27
Capital Market Ratios 27
Equity Ratios 28
Profitability Ratios 28
Cost Ratios 29
Liquidity Ratios 29
Leverage Ratios 30
Efficiency Ratios 30

★海外企業調査レポート[Sakai Chemical Industry Co Ltd (4078):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Muehlbauer Holding AG & Co. KGaA (MUB):企業の財務・戦略的SWOT分析
    Muehlbauer Holding AG & Co. KGaA (MUB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Mediolanum farmaceutici SpA-製薬・医療分野:企業M&A・提携分析
    Summary Mediolanum farmaceutici SpA (Mediolanum) is a healthcare solution provider that discovers, develops and markets pharmaceuticals products and prescription drugs. The company offers products in therapeutic areas which include neuropsychiatric, osteoarticular, antibiotic, pneumoallergological, …
  • Erytech Pharma SA (ERYP):企業の財務・戦略的SWOT分析
    Summary Erytech Pharma SA (ERYTECH Pharma) is a clinical-stage biopharmaceutical company developing red blood cell-based therapeutics for cancer and orphan diseases. Its pipeline product candidates include erymethionase (methionine-?-lyase), a novel amino acid agent targeting cancer metabolism in so …
  • Biglari Holdings Inc.:戦略・SWOT・企業財務分析
    Biglari Holdings Inc. - Strategy, SWOT and Corporate Finance Report Summary Biglari Holdings Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • NicozDiamond Insurance Limited:企業の戦略・SWOT・財務分析
    NicozDiamond Insurance Limited - Strategy, SWOT and Corporate Finance Report Summary NicozDiamond Insurance Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Suzhou Xinrong Best Medical Instrument Co Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Suzhou Xinrong Best Medical Instrument Co Ltd (Suzhou Xinrong) is a medical device company that manufactures orthopedic medical instruments. The company offers products such as medullary cavity plug, acetabular screws, metal ball head, stem and titanium plate anterior thoracolumbar fixed equ …
  • MannKind Corp (MNKD)-医療機器分野:企業M&A・提携分析
    Summary MannKind Corp (MannKind) is a biopharmaceutical company that discovers, develops and commercializes therapeutic products to treat diseases such as diabetes. The company’s lead product, Afrezza is a rapid-acting, inhaled insulin used to control high blood sugar in adults with type 1 and type …
  • Compass Health Brands Corp:医療機器:M&Aディール及び事業提携情報
    Summary Compass Health Brands Corp (Compass Health) is a holding company. The company, through its subsidiaries, manufactures and markets medical equipment and devices. It offers bath safety, personal care, durable medical equipment, support surfaces, pressure prevention, mobility, pain management, …
  • Baldwin & Lyons Inc:企業の戦略・SWOT・財務情報
    Baldwin & Lyons Inc - Strategy, SWOT and Corporate Finance Report Summary Baldwin & Lyons Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Tribune Media Co:企業の戦略的SWOT分析
    Tribune Media Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Associated Electric Cooperative Inc.:企業の発電所・SWOT分析2018
    Associated Electric Cooperative Inc. - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information …
  • Isto Biologics-医療機器分野:企業M&A・提携分析
    Summary Isto Biologics (Isto), formerly ISTO Technologies Inc, is an orthobiologics company which manufactures and develops products to treat orthopedic and spine disorders. The company offers solutions in cell therapy and rapid bone healing. Its product portfolio includes InQu, a bone graft extende …
  • SHI International Corp.:企業の戦略的SWOT分析
    SHI International Corp. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Bellvitge Biomedical Research Institute-製薬・医療分野:企業M&A・提携分析
    Summary Bellvitge Biomedical Research Institute (IDIBELL) is a research centre focused on cellular medicine. It conducts clinical and basic research for developing treatments and techniques to improve health care. IDIBELL carries its research work in the fields of cancer and human molecular genetics …
  • Dexia Group:企業のM&A・事業提携・投資動向
    Dexia Group - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Dexia Group Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • Neusoft Medical Systems Co Ltd-医療機器分野:企業M&A・提携分析
    Summary Neusoft Medical Systems Co Ltd (Neusoft Medical), a subsidiary of Neusoft Corp is a medical device company that provides medical equipment and services. The company offers medical imaging equipment, e-hospital solutions, regional medical and personal healthcare products. Its product portfoli …
  • CeraPedics Inc:医療機器:M&Aディール及び事業提携情報
    Summary CeraPedics Inc (Cerapedics) is a medical device company that develops and commercializes novel osteobiologic products. The company’s products include i-factor putty, a biologic bone graft that uses a unique small peptide attachment factor to target specific integrins in osteogenic cells to i …
  • Maxion Wheels Inc:企業の戦略的SWOT分析
    Maxion Wheels Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Citla Energy SAPI de CV:石油・ガス:M&Aディール及び事業提携情報
    Summary Citla Energy SAPI de CV (Citla Energy) is an oil and gas company that offers crude oil and natural gas exploration and production services. The company acquires and builds a portfolio of selected onshore and offshore assets independently and with other industry participants. It also provides …
  • McLane Company Inc:戦略・SWOT・企業財務分析
    McLane Company Inc - Strategy, SWOT and Corporate Finance Report Summary McLane Company Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆